# XIENCE V: SPIRIT WOMEN

> **NCT00496938** · PHASE4 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1600 (actual)

## Conditions studied

- Coronary Artery Stenosis
- Coronary Arteriosclerosis
- Coronary Artery Disease
- Coronary Artery Restenosis
- Total Coronary Occlusion
- Stent Thrombosis
- Vascular Disease
- Myocardial Ischemia

## Interventions

- **DEVICE:** XIENCE V®/ XIENCE PRIME™

## Key facts

- **NCT ID:** NCT00496938
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-08
- **Final completion:** 2011-07
- **Target enrollment:** 1600 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496938, "XIENCE V: SPIRIT WOMEN". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00496938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
